Evaluation of the immune response to Anaplasma marginale MSP5 protein using a HSV-1 amplicon vector system or recombinant protein
Anaplasma marginale is an intraerythrocytic vector-borne infectious agent of cattle. Immunization with the current vaccine, based on parasitized erythrocytes with live Anaplasma centrale, shows some constraints and confers partial protection, suggesting the feasibility for the development of new generation of vaccines. The aim of the present study was to assess the effect of sequential immunization of BALB/c mice, with herpesvirus amplicon vector-based vaccines combined with protein-based vaccines, on the quality of the immune response against the major surface protein 5 of A. marginale. The highest antibody titers against MSP5 were elicited in mice that received two doses of adjuvanted recombinant protein (p < 0.0001). Mice treated with a heterologous prime-boost strategy generated sustained antibody titers at least up to 200 days, and a higher specific cellular response. The results presented here showed that sequential immunization with HSV-based vectors and purified antigen enhances the quality of the immune response against A. marginale.
Auteurs principaux: | Palacios, Carlos Adolfo, Torioni, Susana Marta, Mattion, Nora Marta |
---|---|
Format: | info:ar-repo/semantics/artículo biblioteca |
Langue: | eng |
Publié: |
2014-12
|
Sujets: | Anaplasma Marginale, Respuesta Inmunológica, Proteínas Recombinantes, Vectores, Ganado Bovino, Immune Response, Recombinant Proteins, Vectors, Cattle, |
Accès en ligne: | https://www.sciencedirect.com/science/article/pii/S003452881400294X http://hdl.handle.net/20.500.12123/3028 https://doi.org/10.1016/j.rvsc.2014.10.005 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
A prime-boost combination of a three-protein cocktail and multiepitopic MVA as a vaccine against Babesia bigemina elicits neutralizing antibodies and a Th1 cellular immune response in mice
par: Montenegro, Valeria Noely, et autres
Publié: (2022-09) -
A vaccine using Anaplasma marginale subdominant type IV secretion system recombinant proteins was not protective against a virulent challenge
par: Sarli, Macarena, et autres
Publié: (2020-02) -
Imunização de bovinos com MSP1a e MSP2 recombinantes de Anaplasma marginale com CpG ODN 2006 como adjuvante, e desafio com isolado heterólogo.
par: ARAÚJO, F. R., et autres
Publié: (2006) -
ELISA com MSP5 recombinante truncada para detecção de anticorpos contra Anaplasma marginale em bovinos.
par: ARAÚJO, F. R. de, et autres
Publié: (2006) -
Development of a novel fusion protein with Anaplasma marginale and A. centrale MSP5 improved performance of Anaplasma antibody detection by cELISA in infected and vaccinated cattle
par: Primo, María Evangelina, et autres
Publié: (2019-01-23)